Barrett & Company’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.42M Buy
9,547
+774
+9% +$180K 0.68% 32
2026
Q1
$2.14M Buy
8,773
+194
+2% +$45.2K 0.74% 31
2025
Q4
$1.78M Sell
8,579
-517
-6% -$102K 0.59% 33
2025
Q3
$1.69M Sell
9,096
-614
-6% -$105K 0.58% 33
2025
Q2
$1.48M Buy
9,710
+105
+1% +$16.1K 0.56% 33
2025
Q1
$1.59M Buy
9,605
+9
+0.1% +$1.41K 0.69% 31
2024
Q4
$1.39M Sell
9,596
-22
-0.2% -$3.41K 0.59% 34
2024
Q3
$1.56M Sell
9,618
-370
-4% -$59K 0.68% 32
2024
Q2
$1.46M Buy
9,988
+70
+0.7% +$10.4K 0.66% 32
2024
Q1
$1.57M Buy
9,918
+121
+1% +$19.3K 0.74% 29
2023
Q4
$1.54M Sell
9,797
-433
-4% -$66.4K 0.83% 25
2023
Q3
$1.59M Buy
10,230
+464
+5% +$76.6K 0.94% 24
2023
Q2
$1.62M Buy
9,766
+508
+5% +$82K 0.94% 23
2023
Q1
$1.43M Buy
9,258
+58
+0.6% +$9.37K 0.91% 23
2022
Q4
$1.63M Hold
9,200
1.07% 23
2022
Q3
$1.63M Buy
+9,200
New +$1.56M 1.07% 23

Other funds holding JNJ

Barrett & Company's JNJ Position: Q2 2026 in Review

Barrett & Company increased its Johnson & Johnson (JNJ) stake by 8.8% in Q2 2026, buying an estimated $180K and bringing the position to 9,547 shares worth $2.42M. The position accounts for 0.68% of the portfolio, ranked #32.

Barrett & Company first reported a position in JNJ in Q3 2022 and has held it in 16 quarters since. 2,379 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Barrett & Company held 9,547 shares of Johnson & Johnson worth $2.42M as of Q2 2026.
  • Barrett & Company bought 774 Johnson & Johnson shares in Q2 2026, an estimated $180K.
  • Johnson & Johnson made up 0.68% of Barrett & Company's portfolio in Q2 2026, its #32 holding.
  • Barrett & Company first reported a position in Johnson & Johnson in Q3 2022 and has held it in 16 quarters since.
  • 2,379 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Barrett & Company's 13F filing for Q2 2026, filed 24 Jul 2026.